Disease burden and conditioning regimens in ASCT1221, a randomized phase II trial in children with juvenile myelomonocytic leukemia: A Children's Oncology Group study.

Dvorak, Christopher C; Satwani, Prakash; Stieglitz, Elliot; Cairo, Mitchell S; Dang, Ha; Pei, Qinglin; Gao, Yun; Wall, Donna; Mazor, Tali; Olshen, Adam B; Parker, Joel S; Kahwash, Samir; Hirsch, Betsy; Raimondi, Susana; Patel, Neil; Skeens, Micah; Cooper, Todd; Mehta, Parinda A; Grupp, Stephan A; Loh, Mignon L.
Pediatr Blood Cancer; 65(7): e27034, 2018 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-29528181